ID   CAR1_DICDI              Reviewed;         392 AA.
AC   P13773; Q557I7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   02-DEC-2020, entry version 144.
DE   RecName: Full=Cyclic AMP receptor 1;
DE            Short=cAMP receptor 1;
GN   Name=carA-1; Synonyms=car1; ORFNames=DDB_G0273397;
GN   and
GN   Name=carA-2; Synonyms=car1; ORFNames=DDB_G0273533;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Evosea; Eumycetozoa; Dictyostelia; Dictyosteliales;
OC   Dictyosteliaceae; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=3047871; DOI=10.1126/science.3047871;
RA   Klein P.S., Sun T.J., Saxe C.L. III, Kimmel A.R., Johnson R.L.,
RA   Devreotes P.N.;
RT   "A chemoattractant receptor controls development in Dictyostelium
RT   discoideum.";
RL   Science 241:1467-1472(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=12097910; DOI=10.1038/nature00847;
RA   Gloeckner G., Eichinger L., Szafranski K., Pachebat J.A., Bankier A.T.,
RA   Dear P.H., Lehmann R., Baumgart C., Parra G., Abril J.F., Guigo R.,
RA   Kumpf K., Tunggal B., Cox E.C., Quail M.A., Platzer M., Rosenthal A.,
RA   Noegel A.A.;
RT   "Sequence and analysis of chromosome 2 of Dictyostelium discoideum.";
RL   Nature 418:79-85(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A., Sucgang R.,
RA   Berriman M., Song J., Olsen R., Szafranski K., Xu Q., Tunggal B.,
RA   Kummerfeld S., Madera M., Konfortov B.A., Rivero F., Bankier A.T.,
RA   Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P., Pilcher K., Chen G.,
RA   Saunders D., Sodergren E.J., Davis P., Kerhornou A., Nie X., Hall N.,
RA   Anjard C., Hemphill L., Bason N., Farbrother P., Desany B., Just E.,
RA   Morio T., Rost R., Churcher C.M., Cooper J., Haydock S., van Driessche N.,
RA   Cronin A., Goodhead I., Muzny D.M., Mourier T., Pain A., Lu M., Harper D.,
RA   Lindsay R., Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C., Quail M.A.,
RA   Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D., Sanders M.,
RA   Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S., Tivey A.,
RA   Sugano S., White B., Walker D., Woodward J.R., Winckler T., Tanaka Y.,
RA   Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A., Cox E.C.,
RA   Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M., Kay R.R.,
RA   Williams J.G., Dear P.H., Noegel A.A., Barrell B.G., Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [4]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=1692327; DOI=10.1083/jcb.110.5.1549;
RA   Sun T.J., Van Haastert P.J.M., Devreotes P.N.;
RT   "Surface cAMP receptors mediate multiple responses during development in
RT   Dictyostelium: evidenced by antisense mutagenesis.";
RL   J. Cell Biol. 110:1549-1554(1990).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=1989903; DOI=10.1101/gad.5.1.1;
RA   Saxe C.L. III, Johnson R.L., Devreotes P.N., Kimmel A.R.;
RT   "Expression of a cAMP receptor gene of Dictyostelium and evidence for a
RT   multigene family.";
RL   Genes Dev. 5:1-8(1991).
RN   [6]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=1849108; DOI=10.1101/gad.5.4.572;
RA   Sun T.J., Devreotes P.N.;
RT   "Gene targeting of the aggregation stage cAMP receptor cAR1 in
RT   Dictyostelium.";
RL   Genes Dev. 5:572-582(1991).
RN   [7]
RP   INDUCTION.
RX   PubMed=8392183; DOI=10.1073/pnas.90.13.5969;
RA   Louis J.M., Saxe C.L. III, Kimmel A.R.;
RT   "Two transmembrane signaling mechanisms control expression of the cAMP
RT   receptor gene CAR1 during Dictyostelium development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5969-5973(1993).
RN   [8]
RP   FUNCTION.
RX   PubMed=7925004;
RA   Soede R.D.M., Insall R.H., Devreotes P.N., Schaap P.;
RT   "Extracellular cAMP can restore development in Dictyostelium cells lacking
RT   one, but not two subtypes of early cAMP receptors (cARs). Evidence for
RT   involvement of cAR1 in aggregative gene expression.";
RL   Development 120:1997-2002(1994).
RN   [9]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=8150078; DOI=10.1016/0014-5793(94)80509-1;
RA   Abe F., Maeda Y.;
RT   "Precise expression of the cAMP receptor gene, CAR1, during transition from
RT   growth to differentiation in Dictyostelium discoideum.";
RL   FEBS Lett. 342:239-241(1994).
RN   [10]
RP   PHOSPHORYLATION, AND MUTAGENESIS OF SER-299; SER-302; SER-303; SER-304;
RP   SER-308; SER-324; SER-325; SER-331; 360-SER--SER-368; SER-383 AND SER-385.
RX   PubMed=8120068;
RA   Hereld D., Vaughan R., Kim J.-Y., Borleis J.A., Devreotes P.N.;
RT   "Localization of ligand-induced phosphorylation sites to serine clusters in
RT   the C-terminal domain of the Dictyostelium cAMP receptor, cAR1.";
RL   J. Biol. Chem. 269:7036-7044(1994).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7876207; DOI=10.1074/jbc.270.9.4418;
RA   Caterina M.J., Hereld D., Devreotes P.N.;
RT   "Occupancy of the Dictyostelium cAMP receptor, cAR1, induces a reduction in
RT   affinity which depends upon COOH-terminal serine residues.";
RL   J. Biol. Chem. 270:4418-4423(1995).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9334341; DOI=10.1083/jcb.139.2.365;
RA   Xiao Z., Zhang N., Murphy D.B., Devreotes P.N.;
RT   "Dynamic distribution of chemoattractant receptors in living cells during
RT   chemotaxis and persistent stimulation.";
RL   J. Cell Biol. 139:365-374(1997).
RN   [13]
RP   PHOSPHORYLATION AT SER-302; SER-303 AND SER-304, AND MUTAGENESIS OF
RP   SER-299; SER-302; SER-303 AND SER-304.
RX   PubMed=7721769; DOI=10.1074/jbc.270.15.8667;
RA   Caterina M.J., Devreotes P.N., Borleis J.A., Hereld D.;
RT   "Agonist-induced loss of ligand binding is correlated with phosphorylation
RT   of cAR1, a G protein-coupled chemoattractant receptor from Dictyostelium.";
RL   J. Biol. Chem. 270:8667-8672(1995).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF 288-LYS--ASN-392.
RX   PubMed=9341180; DOI=10.1074/jbc.272.43.27313;
RA   Kim J.-Y., Soede R.D.M., Schaap P., Valkema R., Borleis J.A.,
RA   Van Haastert P.J.M., Devreotes P.N., Hereld D.;
RT   "Phosphorylation of chemoattractant receptors is not essential for
RT   chemotaxis or termination of G-protein-mediated responses.";
RL   J. Biol. Chem. 272:27313-27318(1997).
RN   [15]
RP   FUNCTION, AND MUTAGENESIS OF ASN-148; VAL-154; SER-155; PHE-156 AND
RP   THR-157.
RX   PubMed=9578623; DOI=10.1006/dbio.1998.8882;
RA   Kim J.-Y., Borleis J.A., Devreotes P.N.;
RT   "Switching of chemoattractant receptors programs development and
RT   morphogenesis in Dictyostelium: receptor subtypes activate common responses
RT   at different agonist concentrations.";
RL   Dev. Biol. 197:117-128(1998).
RN   [16]
RP   PHOSPHORYLATION.
RX   PubMed=9880518; DOI=10.1074/jbc.274.3.1440;
RA   Xiao Z., Yao Y., Long Y., Devreotes P.N.;
RT   "Desensitization of G-protein-coupled receptors. agonist-induced
RT   phosphorylation of the chemoattractant receptor cAR1 lowers its intrinsic
RT   affinity for cAMP.";
RL   J. Biol. Chem. 274:1440-1448(1999).
RN   [17]
RP   FUNCTION.
RX   PubMed=11319871; DOI=10.1006/dbio.2001.0217;
RA   Briscoe C., Moniakis J., Kim J.-Y., Brown J.M., Hereld D., Devreotes P.N.,
RA   Firtel R.A.;
RT   "The phosphorylated C-terminus of cAR1 plays a role in cell-type-specific
RT   gene expression and STATa tyrosine phosphorylation.";
RL   Dev. Biol. 233:225-236(2001).
RN   [18]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11422293; DOI=10.1046/j.1440-169x.2001.00572.x;
RA   Tsujioka M., Yokoyama M., Nishio K., Kuwayama H., Morio T., Katoh M.,
RA   Urushihara H., Saito T., Ochiai H., Tanaka Y., Takeuchi I., Maeda M.;
RT   "Spatial expression patterns of genes involved in cyclic AMP responses in
RT   Dictyostelium discoideum development.";
RL   Dev. Growth Differ. 43:275-283(2001).
RN   [19]
RP   FUNCTION.
RX   PubMed=11559759;
RA   Dormann D., Kim J.-Y., Devreotes P.N., Weijer C.J.;
RT   "cAMP receptor affinity controls wave dynamics, geometry and morphogenesis
RT   in Dictyostelium.";
RL   J. Cell Sci. 114:2513-2523(2001).
RN   [20]
RP   DEVELOPMENTAL STAGE [LARGE SCALE ANALYSIS].
RX   PubMed=11923193;
RA   Van Driessche N., Shaw C., Katoh M., Morio T., Sucgang R., Ibarra M.,
RA   Kuwayama H., Saito T., Urushihara H., Maeda M., Takeuchi I., Ochiai H.,
RA   Eaton W., Tollett J., Halter J., Kuspa A., Tanaka Y., Shaulsky G.;
RT   "A transcriptional profile of multicellular development in Dictyostelium
RT   discoideum.";
RL   Development 129:1543-1552(2002).
RN   [21]
RP   DEVELOPMENTAL STAGE [LARGE SCALE ANALYSIS].
RX   PubMed=12796308; DOI=10.1128/ec.2.3.627-637.2003;
RA   Maeda M., Sakamoto H., Iranfar N., Fuller D., Maruo T., Ogihara S.,
RA   Morio T., Urushihara H., Tanaka Y., Loomis W.F.;
RT   "Changing patterns of gene expression in Dictyostelium prestalk cell
RT   subtypes recognized by in situ hybridization with genes from microarray
RT   analyses.";
RL   Eukaryot. Cell 2:627-637(2003).
RN   [22]
RP   DEVELOPMENTAL STAGE [LARGE SCALE ANALYSIS].
RX   PubMed=12912885; DOI=10.1128/ec.2.4.664-670.2003;
RA   Iranfar N., Fuller D., Loomis W.F.;
RT   "Genome-wide expression analyses of gene regulation during early
RT   development of Dictyostelium discoideum.";
RL   Eukaryot. Cell 2:664-670(2003).
RN   [23]
RP   DEVELOPMENTAL STAGE [LARGE SCALE ANALYSIS].
RX   PubMed=15470253; DOI=10.1128/ec.3.5.1241-1248.2004;
RA   Maruo T., Sakamoto H., Iranfar N., Fuller D., Morio T., Urushihara H.,
RA   Tanaka Y., Maeda M., Loomis W.F.;
RT   "Control of cell type proportioning in Dictyostelium discoideum by
RT   differentiation-inducing factor as determined by in situ hybridization.";
RL   Eukaryot. Cell 3:1241-1248(2004).
RN   [24]
RP   MUTAGENESIS OF LEU-100; ILE-102; ILE-104; VAL-136 AND ASN-225.
RX   PubMed=15574880; DOI=10.1091/mbc.e04-06-0456;
RA   Zhang M., Goswami M., Hereld D.;
RT   "Constitutively active G protein-coupled receptor mutants block
RT   dictyostelium development.";
RL   Mol. Biol. Cell 16:562-572(2005).
RN   [25]
RP   MUTAGENESIS OF ILE-104.
RX   PubMed=17630977; DOI=10.1111/j.1365-2958.2007.05803.x;
RA   Zhang M., Goswami M., Sawai S., Cox E.C., Hereld D.;
RT   "Regulation of G protein-coupled cAMP receptor activation by a hydrophobic
RT   residue in transmembrane helix 3.";
RL   Mol. Microbiol. 65:508-520(2007).
CC   -!- FUNCTION: Receptor for cAMP. Coordinates the aggregation of individual
CC       cells into a multicellular organism and regulates the expression of a
CC       large number of developmentally regulated genes. The activity of this
CC       receptor is mediated by G proteins. {ECO:0000269|PubMed:11319871,
CC       ECO:0000269|PubMed:11559759, ECO:0000269|PubMed:1692327,
CC       ECO:0000269|PubMed:1849108, ECO:0000269|PubMed:3047871,
CC       ECO:0000269|PubMed:7925004, ECO:0000269|PubMed:9341180,
CC       ECO:0000269|PubMed:9578623}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:7876207,
CC       ECO:0000269|PubMed:9334341}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:7876207, ECO:0000269|PubMed:9334341}.
CC   -!- DEVELOPMENTAL STAGE: Expressed predominantly during early aggregation
CC       and at low levels during later stage. {ECO:0000269|PubMed:11422293,
CC       ECO:0000269|PubMed:11923193, ECO:0000269|PubMed:12796308,
CC       ECO:0000269|PubMed:12912885, ECO:0000269|PubMed:15470253,
CC       ECO:0000269|PubMed:1692327, ECO:0000269|PubMed:1849108,
CC       ECO:0000269|PubMed:1989903, ECO:0000269|PubMed:8150078}.
CC   -!- PTM: C-terminal Ser or Thr residues may be phosphorylated.
CC       {ECO:0000269|PubMed:7721769, ECO:0000269|PubMed:8120068,
CC       ECO:0000269|PubMed:9880518}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 5 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: The gene for this protein is duplicated in strains AX3 and
CC       AX4. These strains contain a duplication of a segment of 750 kb of
CC       chromosome 2 compared to the corresponding sequence in strain AX2.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M21824; AAA33177.1; -; mRNA.
DR   EMBL; AAFI02000010; EAL70653.1; -; Genomic_DNA.
DR   EMBL; AAFI02000010; EAL70721.1; -; Genomic_DNA.
DR   PIR; A41238; A41238.
DR   RefSeq; XP_644603.1; XM_639511.1.
DR   RefSeq; XP_644648.1; XM_639556.1.
DR   STRING; 44689.DDB0238333; -.
DR   TCDB; 9.A.14.5.1; the g-protein-coupled receptor (gpcr) family.
DR   iPTMnet; P13773; -.
DR   PaxDb; P13773; -.
DR   EnsemblProtists; EAL70653; EAL70653; DDB_G0273397.
DR   EnsemblProtists; EAL70721; EAL70721; DDB_G0273533.
DR   GeneID; 8618967; -.
DR   GeneID; 8619010; -.
DR   KEGG; ddi:DDB_G0273397; -.
DR   KEGG; ddi:DDB_G0273533; -.
DR   dictyBase; DDB_G0273397; carA-1.
DR   dictyBase; DDB_G0273533; carA-2.
DR   eggNOG; ENOG502RYGP; Eukaryota.
DR   HOGENOM; CLU_050319_0_0_1; -.
DR   InParanoid; P13773; -.
DR   OMA; WTLCLAI; -.
DR   PhylomeDB; P13773; -.
DR   PRO; PR:P13773; -.
DR   Proteomes; UP000002195; Chromosome 2.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0031252; C:cell leading edge; IDA:dictyBase.
DR   GO; GO:0009986; C:cell surface; IDA:dictyBase.
DR   GO; GO:0005829; C:cytosol; IDA:dictyBase.
DR   GO; GO:0005769; C:early endosome; IDA:dictyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:dictyBase.
DR   GO; GO:0030552; F:cAMP binding; IDA:dictyBase.
DR   GO; GO:0001646; F:cAMP receptor activity; IDA:dictyBase.
DR   GO; GO:0001637; F:G protein-coupled chemoattractant receptor activity; IDA:dictyBase.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; IGI:dictyBase.
DR   GO; GO:0090630; P:activation of GTPase activity; IMP:dictyBase.
DR   GO; GO:0000187; P:activation of MAPK activity; IMP:dictyBase.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IMP:dictyBase.
DR   GO; GO:0023058; P:adaptation of signaling pathway; IMP:dictyBase.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:dictyBase.
DR   GO; GO:0031152; P:aggregation involved in sorocarp development; IMP:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IMP:dictyBase.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IMP:dictyBase.
DR   GO; GO:0006935; P:chemotaxis; IMP:dictyBase.
DR   GO; GO:0002029; P:desensitization of G protein-coupled receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:1900275; P:negative regulation of phospholipase C activity; IMP:dictyBase.
DR   GO; GO:0106071; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:dictyBase.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IMP:dictyBase.
DR   GO; GO:0097696; P:receptor signaling pathway via STAT; IMP:dictyBase.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0050764; P:regulation of phagocytosis; IMP:dictyBase.
DR   GO; GO:0046578; P:regulation of Ras protein signal transduction; IMP:dictyBase.
DR   GO; GO:1902168; P:response to catechin; IDA:dictyBase.
DR   GO; GO:1904643; P:response to curcumin; IDA:dictyBase.
DR   GO; GO:1903013; P:response to differentiation-inducing factor 1; HDA:dictyBase.
DR   GO; GO:0010225; P:response to UV-C; IDA:dictyBase.
DR   InterPro; IPR022343; GCR1-cAMP_receptor.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR000848; GPCR_cAMP.
DR   PRINTS; PR02001; GCR1CAMPR.
DR   PRINTS; PR00247; GPCRCAMP.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..392
FT                   /note="Cyclic AMP receptor 1"
FT                   /id="PRO_0000195080"
FT   TOPO_DOM        1..13
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        14..33
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        34..47
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        48..68
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        69..83
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        84..109
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        110..120
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        121..139
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        140..162
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        163..181
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        182..205
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        206..224
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        225..235
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..260
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        261..392
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        337..356
FT                   /note="Asn-rich"
FT   COMPBIAS        360..368
FT                   /note="Ser-rich"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:7721769"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:7721769"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:7721769"
FT   MOD_RES         308
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         100
FT                   /note="L->H: In DN3; constitutive phosphorylation and
FT                   greatly increased affinity for cAMP."
FT                   /evidence="ECO:0000269|PubMed:15574880"
FT   MUTAGEN         102
FT                   /note="I->T: In DN2; constitutive phosphorylation and
FT                   greatly increased affinity for cAMP; when associated with
FT                   D-225."
FT                   /evidence="ECO:0000269|PubMed:15574880"
FT   MUTAGEN         104
FT                   /note="I->N: In DN4; constitutive phosphorylation and
FT                   greatly increased affinity for cAMP. In DN1; Constitutive
FT                   phosphorylation and greatly increased affinity for cAMP;
FT                   when associated with A-136."
FT                   /evidence="ECO:0000269|PubMed:15574880,
FT                   ECO:0000269|PubMed:17630977"
FT   MUTAGEN         104
FT                   /note="I->X: Most substitutions increase affinity for cAMP
FT                   and the most polar substitutions block development."
FT                   /evidence="ECO:0000269|PubMed:15574880,
FT                   ECO:0000269|PubMed:17630977"
FT   MUTAGEN         136
FT                   /note="V->A: In DN1; constitutive phosphorylation and
FT                   greatly increased affinity for cAMP; when associated with
FT                   N-104."
FT                   /evidence="ECO:0000269|PubMed:15574880"
FT   MUTAGEN         148
FT                   /note="N->G: Reduces the affinity for cAMP by 100 to 1000-
FT                   fold when associated with D-154; N-155; Y-156 and D-157."
FT                   /evidence="ECO:0000269|PubMed:9578623"
FT   MUTAGEN         154
FT                   /note="V->D: Reduces the affinity for cAMP by 100 to 1000-
FT                   fold when associated with G-148; N-155; Y-156 and D-157."
FT                   /evidence="ECO:0000269|PubMed:9578623"
FT   MUTAGEN         155
FT                   /note="S->N: Reduces the affinity for cAMP by 100 to 1000-
FT                   fold when associated with G-148; D-154; Y-156 and D-157."
FT                   /evidence="ECO:0000269|PubMed:9578623"
FT   MUTAGEN         156
FT                   /note="F->Y: Reduces the affinity for cAMP by 100 to 1000-
FT                   fold when associated with G-148; D-154; N-155 and D-157."
FT                   /evidence="ECO:0000269|PubMed:9578623"
FT   MUTAGEN         157
FT                   /note="T->D: Reduces the affinity for cAMP by 100 to 1000-
FT                   fold when associated with G-148; D-154; N-155 and Y-156."
FT                   /evidence="ECO:0000269|PubMed:9578623"
FT   MUTAGEN         225
FT                   /note="N->D: In DN2; constitutive phosphorylation and
FT                   greatly increased affinity for cAMP; when associated with
FT                   T-102."
FT                   /evidence="ECO:0000269|PubMed:15574880"
FT   MUTAGEN         288..392
FT                   /note="Missing: No effect on cAMP-dependent gene
FT                   expression, chemotaxis, aggregation and differentiation."
FT                   /evidence="ECO:0000269|PubMed:9341180"
FT   MUTAGEN         299
FT                   /note="S->A: Greatly reduces ligand induced
FT                   phosphorylation; when associated with G-302; A-303; G-304
FT                   and A-308."
FT                   /evidence="ECO:0000269|PubMed:7721769,
FT                   ECO:0000269|PubMed:8120068"
FT   MUTAGEN         302
FT                   /note="S->G: Greatly reduces ligand induced
FT                   phosphorylation; when associated with A-299; A-303; G-304
FT                   and A-308."
FT                   /evidence="ECO:0000269|PubMed:7721769,
FT                   ECO:0000269|PubMed:8120068"
FT   MUTAGEN         303
FT                   /note="S->A: Greatly reduces ligand induced
FT                   phosphorylation; when associated with A-299; G-302; G-304
FT                   and A-308."
FT                   /evidence="ECO:0000269|PubMed:7721769,
FT                   ECO:0000269|PubMed:8120068"
FT   MUTAGEN         304
FT                   /note="S->G: Greatly reduces ligand induced
FT                   phosphorylation; when associated with A-299; G-302; A-303
FT                   and A-308."
FT                   /evidence="ECO:0000269|PubMed:7721769,
FT                   ECO:0000269|PubMed:8120068"
FT   MUTAGEN         308
FT                   /note="S->A: Greatly reduces ligand induced
FT                   phosphorylation; when associated with A-299; G-302; A-303
FT                   and G-304."
FT                   /evidence="ECO:0000269|PubMed:8120068"
FT   MUTAGEN         324
FT                   /note="S->G: Slightly reduces ligand induced and basal
FT                   phosphorylation; when associated with A-325 and A-331."
FT                   /evidence="ECO:0000269|PubMed:8120068"
FT   MUTAGEN         325
FT                   /note="S->A: Slightly reduces ligand induced and basal
FT                   phosphorylation; when associated with G-324 and A-331."
FT                   /evidence="ECO:0000269|PubMed:8120068"
FT   MUTAGEN         331
FT                   /note="S->A: Slightly reduces ligand induced and basal
FT                   phosphorylation; when associated with G-324 and A-325."
FT                   /evidence="ECO:0000269|PubMed:8120068"
FT   MUTAGEN         360..368
FT                   /note="Missing: Greatly reduces basal phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:8120068"
FT   MUTAGEN         383
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:8120068"
FT   MUTAGEN         385
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:8120068"
SQ   SEQUENCE   392 AA;  44312 MW;  38C4561EE1CC9A69 CRC64;
     MGLLDGNPAN ETSLVLLLFA DFSSMLGCMA VLIGFWRLKL LRNHVTKVIA CFCATSFCKD
     FPSTILTLTN TAVNGGFPCY LYAIVITYGS FACWLWTLCL AISIYMLIVK REPEPERFEK
     YYYLLCWGLP LISTIVMLAK NTVQFVGNWC WIGVSFTGYR FGLFYGPFLF IWAISAVLVG
     LTSRYTYVVI HNGVSDNKEK HLTYQFKLIN YIIVFLVCWV FAVVNRIVNG LNMFPPALNI
     LHTYLSVSHG FWASVTFIYN NPLMWRYFGA KILTVFTFFG YFTDVQKKLE KNKNNNNPSP
     YSSSRGTSGK TMGGHPTGDD VQCSSDMEQC SLERHPNMVN NQQNLNNNYG LQQNYNDEGS
     SSSSLSSSDE EKQTVEMQNI QISTSTNGQG NN
//
